Peliosis hepatis is a liver lesion characterised by blood filled cavities bordered by hepatocytes, randomly distributed throughout the hepatic parenchyma.'-7 This lesion has been described in association with various diseases including tuberculosis and haematologic disorders,`and after the administration of various drugs,4 particularly androgens`6 and azathioprine, a thiopurine derivative. 7 We report the case of a patient with acute leukaemia who developed peliosis hepatis after receiving 6-thioguanine, another thiopurine derivative closely related to azathioprine and previously reported as a cause of veno occlusive disease of the liver.` '2 This report broadens the spectrum of liver vascular disorders caused by 6-thioguanine and suggests that peliosis hepatis, veno occlusive disease, sinusoidal dilatation and perisinusoidal fibrosis may be related syndromes resulting from a similar mechanism affecting endothelial cells at different sites.7 13 We suggest that the initial step of liver vascular lesions caused by thiopurine derivatives might result from potentially toxic metabolites common to these drugs, whose formation rate is genetically determined. The mechanisms by which 6-thioguanine, azathioprine and 6-mercaptopurine induce vascular lesions of the liver are unknown. The role of toxic metabolites common to these drugs, however, might be suggested. Indeed, these three thiopurines have several metabolic pathways in common, particularly, the transformation into 6-thioguanine nucleotides by hypoxanthine guanine phosphoribosyltransferase and S-methylation by thiopurine methyltransferase (TPMT) (Fig. 3) .2526 The cytotoxic activity of 6-mercaptopurine is partly caused by the incorporation Fig. 3 Main metabolic pathways of6-thioguanine, azathioprine and 6-mercaptopurine. From these data, it would be tempting to speculate that peliosis hepatis, sinusoidal dilatation, perisinusoidal fibrosis, and veno-occlusive disease caused by thiopurines, might result from the aggression of endothelial cells of sinusoids or centrilobular veins, by toxic 6-thioguanine nucleotides formed in situ or delivered from red blood cells. The risk of developing such toxic reaction may be particularly high in subjects with a high formation rate of 6-thioguanine nucleotides resulting from the genetic deficiency in thiopurine methyltransferase activity. In addition, the concomittent administration of cytosine arabinosine may have further increased the toxicity of 6-thioguanine. Indeed, the combination of both drugs in animals results in increased concentration of 6-thioguanine in the liver.36
